Lv3
260 积分 2025-08-19 加入
Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer
4小时前
求助中
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
5小时前
求助中
中国男性乳腺癌临床诊治实践指南
1天前
已完结
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
1个月前
已完结
HER2-Low Breast Cancer: Pathological and Clinical Landscape
1个月前
已完结
[Chinese expert consensus on the management of clinical pathway and adverse events of trastuzumab deruxtecan (2024 edition)]
1个月前
已完结
Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial
1个月前
已完结
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing
2个月前
已完结
Alternative splicing generates HER2 isoform diversity underlying antibody-drug conjugate resistance in breast cancer
2个月前
已完结
RE: Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
2个月前
已完结
皖公网安备34019202002308
